Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
55,022,720
-
Share change
-
+228,531
-
Total reported value
-
$883,667,022
-
Put/Call ratio
-
0.44%
-
Price per share
-
$16.06
-
Number of holders
-
126
-
Value change
-
+$108,684
-
Number of buys
-
76
-
Number of sells
-
41
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2023
As of 31 Mar 2023 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,022,720 shares of stock of the company.
Largest 10 holders included DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Inc., ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, BVF INC/IL, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, and BRAIDWELL LP.
This table shows 127 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.